+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 35Years - 55Years
All Genders
Healthy Volunteers
ID07750002

Evaluation of NVTIA4 Ergothioneine Capsules for Improving Healthy Aging and Skin Health in Adults 35 to 55 Years

Led by EUROPEAN LIFE SCIENCE RESEARCH ASSOCIATION · Updated on 2026-08-06

50

Participants Needed

1

Research Sites

24 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of NVTIA4 Ergothioneine, a branded dietary supplement ingredient, on healthy aging biomarkers and skin health in adults aged 35 to 55 years. This randomized, double-blind, placebo-controlled clinical trial aims to provide high-quality evidence about the antioxidant and anti-inflammatory potential of this ingredient in promoting healthy aging and maintaining skin condition. Participants will be randomly assigned to receive either capsules containing 30 mg of NVTIA4 Ergothioneine or matching placebo capsules once daily for 12 weeks. The study includes two parallel groups and compares the effects of the ergothioneine supplement to placebo over the treatment period. During the study, participants will undergo assessments including blood tests to measure oxidative stress markers like plasma 8-Hydroxy-2-deoxyguanosine, inflammatory biomarkers, and skin evaluations for elasticity and hydration at baseline and after 12 weeks. Safety will be monitored throughout the study by tracking adverse events. Participants are expected to maintain their usual diet and lifestyle and attend scheduled visits for evaluation during the 12-week treatment period.

CONDITIONS

Brief Title

NVTIA® Ergothioneine for Healthy Aging and Skin Health

Research Team

D

Daniel Harris

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here